Luminex Corp (LMNX):企業の財務・戦略的SWOT分析

◆英語タイトル:Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1335FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Luminex Corp (LMNX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs its proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as pharmaceutical drug discovery; clinical diagnostics; biomedical research including personalized medicine and genomic research. The company sells its products through direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.

Luminex Corp Key Recent Developments

Feb 08,2021: Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
Jan 29,2021: The faces of Luminex: Rico Weterings, customer operations
Jan 12,2021: Luminex pre-release of 4th quarter 2020 revenue
Nov 05,2020: Luminex reports strong third quarter 2020 results
Oct 07,2020: Luminex pre-release of 3rd quarter 2020 revenue

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Luminex Corp – Key Facts
Luminex Corp – Key Employees
Luminex Corp – Key Employee Biographies
Luminex Corp – Major Products and Services
Luminex Corp – History
Luminex Corp – Company Statement
Luminex Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Luminex Corp – Business Description
Business Segment: Assay
Overview
Performance
Business Segment: Consumables
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Royalty
Overview
Performance
Business Segment: Service
Overview
Performance
Key Stats
Business Segment: System
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Performance
R&D Overview
Luminex Corp – Corporate Strategy
Luminex Corp – SWOT Analysis
SWOT Analysis – Overview
Luminex Corp – Strengths
Luminex Corp – Weaknesses
Luminex Corp – Opportunities
Luminex Corp – Threats
Luminex Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Luminex Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Luminex Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Luminex Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 08, 2021: Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
Jan 29, 2021: The faces of Luminex: Rico Weterings, customer operations
Jan 12, 2021: Luminex pre-release of 4th quarter 2020 revenue
Nov 05, 2020: Luminex reports strong third quarter 2020 results
Oct 07, 2020: Luminex pre-release of 3rd quarter 2020 revenue
Oct 07, 2020: For COVID-19 detection and epidemiology, xMAP technology offers unique advantages
Aug 04, 2020: Luminex announces departure of G. Walter Loewenbaum from its Board of Directors
Aug 04, 2020: Luminex reports second quarter 2020 results
Jul 08, 2020: Luminex pre-release of 2nd quarter 2020 revenue
Jun 29, 2020: Luminex: Results of Operations and Financial Condition
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Luminex Corp, Key Facts
Luminex Corp, Key Employees
Luminex Corp, Key Employee Biographies
Luminex Corp, Major Products and Services
Luminex Corp, History
Luminex Corp, Other Locations
Luminex Corp, Subsidiaries
Luminex Corp, Key Competitors
Luminex Corp, Ratios based on current share price
Luminex Corp, Annual Ratios
Luminex Corp, Annual Ratios (Cont...1)
Luminex Corp, Annual Ratios (Cont...2)
Luminex Corp, Interim Ratios
Luminex Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Luminex Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Luminex Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Luminex Corp (LMNX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Majesco:企業の戦略・SWOT・財務情報
    Majesco - Strategy, SWOT and Corporate Finance Report Summary Majesco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • China Resources Land Limited:戦略・SWOT・企業財務分析
    China Resources Land Limited - Strategy, SWOT and Corporate Finance Report Summary China Resources Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The Rank Group Plc (RNK):企業の財務・戦略的SWOT分析
    The Rank Group Plc (RNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CITIC Pacific Limited:戦略・SWOT・企業財務分析
    CITIC Pacific Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Pacific Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Vattenfall AB:企業の戦略的SWOT分析
    Vattenfall AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cascades Inc:戦略・SWOT・企業財務分析
    Cascades Inc - Strategy, SWOT and Corporate Finance Report Summary Cascades Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Balaji Amines Ltd (BALAMINES)
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Verisk Analytics, Inc.:戦略・SWOT・企業財務分析
    Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Uni-President Enterprises Corp:戦略・SWOT・企業財務分析
    Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report Summary Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Alps Alpine Co Ltd (6770):企業の財務・戦略的SWOT分析
    Alps Alpine Co Ltd (6770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Linde AG (LIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. It offers a wide range of compressed, liquefied gases and chemicals. It also offers engineeri …
  • Wartsila Corporation (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corporation (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vess …
  • HD Supply Inc (HDS):企業の財務・戦略的SWOT分析
    HD Supply Inc (HDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • PetroVietnam Fertilizer and Chemicals Corp (DPM):企業の財務・戦略的SWOT分析
    Summary PetroVietnam Fertilizer and Chemicals Corp (PVFCC), formerly Petrovietnam Fertilizer and Chemicals Company, a subsidiary of Vietnam National Oil and Gas Group, is a chemical company that produces and trades specialty chemicals and fertilizers. The company’s products include prilled Urea, NPK …
  • PellePharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PellePharm Inc (PellePharm), a subsidiary of BridgeBio Inc, is a biotechnology company that develops and commercializes treatments for rare genetic dermatological conditions. The company’s lead clinical program, Patidegib, is a first-in-class topical gel formulation of a proprietary hedgehog …
  • SunPower Corporation (SPWR):電力:M&Aディール及び事業提携情報
    Summary SunPower Corporation (SunPower), a subsidiary of Total Solar International SAS, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procurement, and …
  • Compagnie Financiere Richemont SA:企業の戦略・SWOT・財務情報
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • NextEra Energy Resources LLC-エネルギー分野:企業M&A・提携分析
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆